Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.
Also called NCT06693011
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Cerus Endovascular, Inc.
- Registry
-
NCT06693011
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06693011. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-10 (actual); primary completion 2028-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
- Acronym
- NEXT
- Condition
- Cerebral Aneurysms
- Intervention (Device)
- Contour Neurovascular System Treatment Attempt
- Lead sponsor
- Cerus Endovascular, Inc.
Record details
- Record id
cardio:ct-nct06693011- Content hash
6fe64d84df7e1f654f105633460f1c56a8bef75e97d29c60c3e4eeb552735926